Advertisement

Topics

Sanofi and Regeneron Launch Major New Immuno-Oncology Collaboration

03:01 EDT 28 Jul 2015 | GlobalNewsWire (2014)

This article has expired, however you can still download the PDF.
Preview:
Sanofi and Regeneron Launch Major New Immuno-Oncology Collaboration - Companies agree to jointly advance PD-1 and other new immuno-oncology antibodies - - Sanofi commits to an initial investment of up to $2.17 billion in the exc...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Sanofi and Regeneron Launch Major New Immuno-Oncology Collaboration"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...